Susquehanna International Group
TXG icon

Susquehanna International Group’s 10x Genomics TXG Stock Holding History

Susquehanna International Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.21M Buy
150,980
+97,452
+182% +$1.95M ﹤0.01% 5146
2025
Q4 		$873K Sell
53,528
-54,846
-51% -$829K ﹤0.01% 7488
2025
Q3 		$1.27M Sell
108,374
-95,435
-47% -$1.24M ﹤0.01% 6767
2025
Q2 		$2.36M Sell
203,809
-763,942
-79% -$6.96M ﹤0.01% 5439
2025
Q1 		$8.45M Buy
967,751
+879,491
+996% +$11.1M ﹤0.01% 2753
2024
Q4 		$1.27M Buy
88,260
+33,666
+62% +$531K ﹤0.01% 6389
2024
Q3 		$1.23M Sell
54,594
-36,487
-40% -$754K ﹤0.01% 6332
2024
Q2 		$1.77M Buy
91,081
+53,219
+141% +$1.39M ﹤0.01% 5329
2024
Q1 		$1.42M Sell
37,862
-14,192
-27% -$624K ﹤0.01% 6126
2023
Q4 		$2.91M Buy
52,054
+41,177
+379% +$1.79M ﹤0.01% 4632
2023
Q3 		$449K Buy
+10,877
New +$566K ﹤0.01% 8489
2023
Q2 		– Sell
-3,911
Closed -$212K – 13165
2023
Q1 		$218K Sell
3,911
-3,548
-48% -$166K ﹤0.01% 10412
2022
Q4 		$272K Sell
7,459
-73,518
-91% -$2.4M ﹤0.01% 9336
2022
Q3 		$2.31M Buy
80,977
+66,028
+442% +$2.52M ﹤0.01% 4630
2022
Q2 		$676K Buy
+14,949
New +$776K ﹤0.01% 7516
2022
Q1 		– Sell
-42,291
Closed -$3.7M – 14001
2021
Q4 		$6.3M Buy
42,291
+1,346
+3% +$206K ﹤0.01% 3370
2021
Q3 		$5.96M Buy
40,945
+25,956
+173% +$4.46M ﹤0.01% 3639
2021
Q2 		$2.94M Buy
14,989
+11,460
+325% +$2.07M ﹤0.01% 5071
2021
Q1 		$639K Sell
3,529
-34,615
-91% -$5.98M ﹤0.01% 8900
2020
Q4 		$5.4M Buy
+38,144
New +$5.54M ﹤0.01% 3299
2020
Q2 		– Sell
-24,833
Closed -$1.93M – 10958
2020
Q1 		$1.55M Buy
24,833
+20,404
+461% +$1.59M ﹤0.01% 4435
2019
Q4 		$338K Sell
4,429
-5,980
-57% -$360K ﹤0.01% 7794
2019
Q3 		$525K Buy
+10,409
New +$576K ﹤0.01% 7208

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group's TXG Position: Q1 2026 in Review

Susquehanna International Group increased its 10x Genomics (TXG) stake by 182% in Q1 2026, buying an estimated $1.95M and bringing the position to 150,980 shares worth $3.21M. The position accounts for ﹤0.01% of the portfolio, ranked #5146.

Susquehanna International Group first reported a position in TXG in Q3 2019 and has held it in 23 quarters since. The position peaked at $8.45M in Q1 2025. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Susquehanna International Group held 150,980 shares of 10x Genomics worth $3.21M as of Q1 2026.
  • Susquehanna International Group bought 97,452 10x Genomics shares in Q1 2026, an estimated $1.95M.
  • 10x Genomics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5146 holding.
  • Susquehanna International Group first reported a position in 10x Genomics in Q3 2019 and has held it in 23 quarters since.
  • Susquehanna International Group's 10x Genomics position peaked at $8.45M in Q1 2025.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.